At the 70% Osmotic Stress (OS) level, compared to the control, treatment with 0.4CMC-BC exhibited a 9.26% decrease in SOD activity, while 0.4GA3-BC resulted in a more substantial 20.02% decrease. This evidence concerns the gene SOD1 and breast cancer.